Glycobiology Advance Access published online on August 17, 2006
Glycobiology, doi:10.1093/glycob/cwl037
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Medical Biochemistry and Molecular Biology, University of Rostock, Schillingallee 70, D-18057 Rostock, Germany
* To whom correspondence should be addressed. To elucidate the role of N-linked glycans in triggering T cell functions the effects of the N-glycan processing inhibitors 1-deoxymannojirimycin (1-DMM) and swainsonine (SW) were investigated on signaling events and induction of apoptosis in galectin-1 (gal-1) stimulated Jurkat T-lymphocytes. Treatment of Jurkat E6.1 cells with 1-DMM and SW strongly reduced the cell binding of gal-1-biotin, conjugate binding to cell lysate glycoproteins, and to CD3-immunoprecipitates on blots as well as the binding of CD2 and CD3 to immobilized gal-1. The mannosidase inhibitors efficiently decreased gal-1 induced calcium mobilization. Both phases originated from a transient Ca2+-release of internal stores and the sustained influx across the plasma membrane were found to be involved. Both inhibitors suppressed in transiently transfected Jurkat T-lymphocytes the gal-1 induced expression of the luciferase reporter gene constructs pNFAT-TA-Luc and pAP1(PMA)-TA-Luc. The data provide evidence that gal-1 triggers through binding to N-linked glycans a Ca2+-sensitive apoptotic pathway.
Received June 2, 2006
Revised July 12, 2006
Accepted August 4, 2006
Article
Effects of N-glycan processing inhibitors on signaling events and induction of apoptosis in galectin-1 stimulated Jurkat T lymphocytes
Hermann Walzel 1 *, Abdelgawad A. Fahmi 2, Mohamed A. Eldesouky 2, Ehab F. Abou-Eladab 3, Grit Waitz 1, Josef Brock 1, and Markus Tiedge 1
2 Cairo University, Faculty of Science, Chemistry Department, Egypt
3 Mansoura University, Faculty of Specific Education, New Damietta City, Egypt
Hermann Walzel, E-mail: hermann.walzel{at}med.uni-rostock.de
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Nishi, A. Abe, J. Iwaki, H. Yoshida, A. Itoh, H. Shoji, S. Kamitori, J. Hirabayashi, and T. Nakamura Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1 Glycobiology, December 1, 2008; 18(12): 1065 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Tao, Y. Li, J. Zhou, J. Qian, R. L Schnaar, Y. Zhang, I. J Goldstein, H. Zhu, and J. P Schneck Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers Glycobiology, October 1, 2008; 18(10): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karmakar, S. R Stowell, R. D Cummings, and R. P McEver Galectin-1 signaling in leukocytes requires expression of complex-type N-glycans Glycobiology, October 1, 2008; 18(10): 770 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bi, L. A. Earl, L. Jacobs, and L. G. Baum Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways J. Biol. Chem., May 2, 2008; 283(18): 12248 - 12258. [Abstract] [Full Text] [PDF] |
||||

